Filing Details
- Accession Number:
- 0001144204-17-012941
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-06 16:05:41
- Reporting Period:
- 2017-03-06
- Filing Date:
- 2017-03-06
- Accepted Time:
- 2017-03-06 16:05:41
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1372514 | Eyegate Pharmaceuticals Inc | EYEG | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1619731 | Morton Goldberg | C/O Eyegate Pharmaceuticals, Inc. 271 Waverley Oaks Road, Suite 108 Waltham MA 02452 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2017-03-06 | 8,919 | $3.00 | 9,441 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Billionaire Hedge Funds
